Published in Vopr Virusol on March 12, 1998
A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res (2000) 5.88
A Ubiquitous Chronic Disease Care system using cellular phones and the internet. Diabet Med (2009) 1.77
Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. Vaccine (2006) 1.16
Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells. Eur Surg Res (2007) 1.05
Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2) influenza virus: sequence analysis of live cold-adapted reassortant vaccine strains before and after replication in children. J Gen Virol (1995) 1.04
The association between the ratio of visceral fat to thigh muscle area and metabolic syndrome: the Korean Sarcopenic Obesity Study (KSOS). Clin Endocrinol (Oxf) (2010) 1.00
Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obese women. Clin Endocrinol (Oxf) (2008) 0.99
Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine. Clin Vaccine Immunol (2011) 0.99
[The frequency of antibodies against delta virus in patients with HBs positive hepatitis]. Vopr Virusol (1997) 0.90
Percentage of the population at high risk of osteoporotic fracture in South Korea: analysis of the 2010 Fifth Korean National Health and Nutrition Examination survey data. Osteoporos Int (2013) 0.89
[Monoclonal immunoenzyme test-system for evaluating secretory immunity to influenza A and B viruses]. Vopr Virusol (1998) 0.85
[Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine]. Mol Gen Mikrobiol Virusol (2011) 0.84
[A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity]. Vopr Virusol (1994) 0.81
[Role of antineuraminidase antibodies in the human immunological response to the administration of live type A influenza vaccines]. Mikrobiol Zh (1981) 0.81
[Restriction analysis of genome composition of live influenza vaccine]. Vopr Virusol (2011) 0.80
[Humoral and cell-mediated immune responses in humans to the A/California/07/ 2009 (H1N1) virus, A(H1N1)pdm2009]. Vopr Virusol (2013) 0.79
[PCR restriction analysis of the genome composition of reassortant cold-adapted influenza B virus strains]. Vopr Virusol (2007) 0.78
[Study of biological properties of cold-adapted reassortant strain of influenza virus subtype H7N3]. Zh Mikrobiol Epidemiol Immunobiol (2009) 0.78
[Indicators of collective immunity to influenza depending on the blood group and sex of the population]. Vopr Virusol (1989) 0.78
[Phenotyte of epidemic influenza B virus strains isolated in different years]. Vopr Virusol (2006) 0.78
[Efficacy of production of reassortant of epidemic strains and cold-adapted influenza viruses in chicken embryo and MDCK cells]. Zh Mikrobiol Epidemiol Immunobiol (2008) 0.78
Associations of Low Muscle Mass and the Metabolic Syndrome in Caucasian and Asian Middle-aged and Older Adults. J Nutr Health Aging (2016) 0.77
[Stimulation of homo- and heterologic T-cell immunological memory in volunteers inoculated with live influenza A (H5N2) reassortant vaccine]. Vopr Virusol (2012) 0.77
[Effect of Point Mutations in the Polymerase Genes of the Influenza A/PR/8/34 (H1N1) Virus on the Immune Response in a Mouse Model]. Vopr Virusol (2015) 0.77
[The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years]. Vopr Virusol (2002) 0.77
Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia: I. Safety and efficacy in two Moscow schools, 1987/88. Vaccine (1993) 0.77
Associated seroconversions to respiratory viruses in volunteers with experimental influenza infection. Acta Virol (1976) 0.77
[A comparative study of the inoculation properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8- to 15-year-old children]. Vopr Virusol (1992) 0.77
[Antibody functional activity in immunization with influenza vaccines]. Vopr Virusol (1994) 0.77
[Evaluation of mass influenza prevention effectiveness using an inactivated chromatographic vaccine in Leningrad]. Zh Mikrobiol Epidemiol Immunobiol (1980) 0.76
T lymphocytes as an indicator in influenza vaccination, influenza and acute respiratory diseases. Acta Virol (1978) 0.76
[The inoculation properties of live recombinant influenza vaccine types A and B used separately and jointly in children 3 to 14]. Vopr Virusol (1992) 0.76
[Prophylactic effectiveness of a live recombinant influenza type A vaccine in immunizing children aged 3-14 years]. Vopr Virusol (1996) 0.76
A case of primary intestinal lymphangiectasia. Korean J Intern Med (1993) 0.75
A case of biliary cystadenocarcinoma. Korean J Intern Med (1997) 0.75
[Formation of antibodies against neuraminidase of A/California/07/2009 (H1N1) influenza virus after immunization with live monovalent influenza vaccine]. Zh Mikrobiol Epidemiol Immunobiol (2012) 0.75
[Formation and protective functions of antibodies to neuraminidase of the influenza A virus]. Vopr Virusol (1985) 0.75
[Characteristics of the immunologic response to Mycoplasma pneumoniae as a polyclonal lymphocyte activator]. Zh Mikrobiol Epidemiol Immunobiol (1988) 0.75
[Local antibody immune responses in influenza patients and persons vaccinated with seasonal, pre-pandemic, and pandemic live attenuated influenza vaccines]. Vopr Virusol (2013) 0.75
Trifurcated hepatic duct with low union complicated by choledocholithiasis. Endoscopy (2013) 0.75
[Influenza vaccine stimulation of antibodies to different variants of influenza A virus]. Vopr Virusol (1985) 0.75
[The generation and characteristics of reassortant influenza A virus with H5 hemagglutinin and other genes from the apathogenic virus H6N2]. Vopr Virusol (2012) 0.75
[Formation of humoral and secretory immunity in elderly persons with different schemes of immunization with flu vaccines]. Vopr Virusol (1998) 0.75
[Production and testing of lyophilized standard preparation for diagnosis of Mycoplasma pneumoniae infection by the indirect hemagglutination test]. Vopr Virusol (1978) 0.75
[Study of the biology of intratype variants of adenovirus serotypes 1, 2, 3, 4 and 7]. Vestn Akad Med Nauk SSSR (1970) 0.75
[Immune response of elderly persons depending on the number of annual seasonal immunizations of live and inactivated influenza vaccines]. Vopr Virusol (1998) 0.75
[Local immune response to live cold-adapted reassortant influenza vaccine in children, adults, and aged people]. Vopr Virusol (2003) 0.75
[Problems for discussion in influenza A immunology]. Vopr Virusol (1981) 0.75
[Heterosubtypic immunity to influenza A viruses: epidemiological data, involvement of different immunological factors, vaccination]. Vopr Virusol (2012) 0.75
RNA-binding protein factor of wheat embryo extracts. FEBS Lett (1975) 0.75
[Estimation of human and animal immunological memory by testing the trogocytosis of virus-specific T lymphocytes]. Vopr Virusol (2011) 0.75
[Significance of the functional activity of antibodies in influenza immunity]. Vestn Ross Akad Med Nauk (1995) 0.75
[Effect of serum antiviral inhibitors on resistance to influenza and acute respiratory diseases]. Vopr Virusol (1973) 0.75
[The immunoprophylaxis of influenza among elderly persons]. Zh Mikrobiol Epidemiol Immunobiol (1997) 0.75
[In vitro proliferative activity of lymphocytes from elderly persons after separate and combined immunization with live and inactivated flu vaccines]. Vopr Virusol (2000) 0.75
[Isolation and characterization of rapidly labelled fractions of cytoplasmic RNA of Aspergillus niger]. Biokhimiia (1973) 0.75
[Production of interleukin-2 in vitro and in vivo in elderly people, vaccinated with live and inactivated flu vaccines separately and combined]. Vopr Virusol (2000) 0.75
[Specific immune response to vaccination with an inactivated flue vaccine depending on prevaccine status and age of the person vaccinated]. Vopr Virusol (2000) 0.75
Education and imaging. Hepatology: Fascioliasis: a rare cause of hepatic pseudoaneurysmal rupture. J Gastroenterol Hepatol (2015) 0.75
[Complex study of population immunity to 3 influenza A virus antigens]. Zh Mikrobiol Epidemiol Immunobiol (1981) 0.75
[Antineuraminidase serum antibodies in natural influenza A and immunization with influenza vaccines]. Vopr Virusol (1983) 0.75
[Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine]. Vopr Virusol (2014) 0.75
[The temperature sensitivity of epidemic influenza A viruses as a marker of immunogenicity of reassortant vaccinal strains]. Vopr Virusol (2003) 0.75
[Organization and evaluation of the effectiveness of emergency prophylaxis and early treatment of influenza with remantadine in Serevodvinsk]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75
[Immune response to live influenza vaccine]. Vestn Ross Akad Med Nauk (2002) 0.75
[The evaluation of the reactogenicity and immunological activity of an inactivated 3-component influenza vaccine with an elevated hemagglutinin concentration in the inoculation dosage]. Zh Mikrobiol Epidemiol Immunobiol (1991) 0.75
[Humoral and local immune response to the influenza vaccine in people of old and young ages]. Vopr Virusol (2003) 0.75
[B-cell and cytotoxic lymphocyte immune response to virulent, attenuated and reassortant influenza viruses]. Vopr Virusol (2002) 0.75
[The use of saliva for study in the immunoenzyme analysis of postvaccinal and postinfectious immunity to influenza]. Vopr Virusol (1994) 0.75
[Formation, persistence period and protective role of antihemagglutinins to earlier circulating influenza A viruses]. Vopr Virusol (1980) 0.75
[Contribution of neuraminidase of influenza viruses to the sensitivity to the serum inhibitors and reassortment efficiency]. Mol Gen Mikrobiol Virusol (2014) 0.75
[Results of a study of collective immunity to influenza A virus (H1N1) from 1976 to 1980]. Vopr Virusol (1982) 0.75
[Testing of apathogenic influenza virus H5N3 as a poultry live vaccine]. Vopr Virusol (2015) 0.75
[The role of antibody functional activity in the protection of people against influenza]. Vopr Virusol (1991) 0.75
[Codon optimization of hemagglutinin as a promising tool for improving of the influenza vaccines immunogenicity]. Mol Gen Mikrobiol Virusol (2014) 0.75
[Evaluation of the anti-neuraminidase antibodies in clinical trials of the live influenza vaccine of the A(H5N2) subtype]. Vopr Virusol (2014) 0.75
[DEVELOPMENT OF THE QUADRIVALENT LIVE ATTENUATED INFLUENZA VACCINE INCLUDING TWO INFLUENZA B LINEAGES--VICTORIA AND YAMAGATA]. Vopr Virusol (2016) 0.75
[Regularities of formation in a general population of serum antibodies to previously circulated influenza A viruses]. Vopr Virusol (1990) 0.75
[A preclinical trial of the reassortant influenza virus vaccine strain A/17/Quail/Hong Kong/97/84 (H9N2)]. Vopr Virusol (2015) 0.75